- Scanned Archives 1989 - 2007
- Donate to Us
- Contact Us
Preliminary Screening for Microsatellite Instability and Loss of Heterozygosity in the Deleted In Colorectal Cancer (DCC) Gene among Filipino Patients with Colorectal Adenocarcinoma
Michael Ernesto S. Arnante,1,2 Ma. Luisa D. Enriquez,1,3 Ernelea P. Cao2
and Filipinas F. Natividad1
1Molecular Cytogenetics Laboratory, Research and Biotechnology,
St. Luke’s Medical Center, Quezon City, Philippines
2Institute of Biology, University of the Philippines Diliman,
Quezon City, Philippines
3Department of Biology / Center for Natural Sciences and Ecological Research,
De La Salle University, Manila, Philippines
Objective. This study aimed to detect the presence of microsatellite (MSI) and loss of heterozygosity (LOH) of the Deleted in Colorectal Cancer (DCC) gene in normal and tumor tissues of Filipino colorectal cancer patients and examine its correlation with age, gender, tumor grade, tumor stage and site of lesion.
Methods. Paired frozen normal and tumor tissues from thirtynine (39) patients with colorectal adenocarcinoma were used by polymerase chain reaction (PCR). Single strand conformation polymorphism - polyacrylamide gel electrophoresis (SSCP - PAGE) was used to determine MSI and restriction fragment length polymorphism (RFLP) was used to study LOH.
Results. Based on our data, out of the 39 patients, 10 showed LOH of the DCC gene using the LOH markers VNTR, M2 and M3, while no MSI was detected in the samples using the MSI markers BAT25 and BAT26. Correlation with clinicopathological characteristics showed that there is significance for the site of lesion. The LOH has correclation with tumor samples from the colon but not with those from the rectum.
Conclusion. Preliminary screening for MSI and LOH of the DCC gene shows that occurrences of colorectal cancer among Filipino patients can be correlated with LOH of the DCC gene with colorectal cancer in a Filipino sample population.
Key Words: DCC gene, loss of heterozygosity, microsatellite, instability, colorectal cancer